CN100496508C - 一种聚甲酚磺醛凝胶剂、其制备方法及药物用途 - Google Patents
一种聚甲酚磺醛凝胶剂、其制备方法及药物用途 Download PDFInfo
- Publication number
- CN100496508C CN100496508C CNB2006100905288A CN200610090528A CN100496508C CN 100496508 C CN100496508 C CN 100496508C CN B2006100905288 A CNB2006100905288 A CN B2006100905288A CN 200610090528 A CN200610090528 A CN 200610090528A CN 100496508 C CN100496508 C CN 100496508C
- Authority
- CN
- China
- Prior art keywords
- policresulen
- gel
- gelling agent
- cmc
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229920001607 Policresulen Polymers 0.000 title claims abstract description 51
- 229960002954 policresulen Drugs 0.000 title claims abstract description 51
- ACZKMKGNTMOPBD-UHFFFAOYSA-N policresulen Chemical compound CC1=CC(O)=C(S(O)(=O)=O)C=C1CC1=CC(S(O)(=O)=O)=C(O)C(CC=2C(=CC(O)=C(C=2)S(O)(=O)=O)C)=C1C ACZKMKGNTMOPBD-UHFFFAOYSA-N 0.000 title claims abstract description 50
- 239000003349 gelling agent Substances 0.000 title claims description 14
- 238000002360 preparation method Methods 0.000 title claims description 12
- 238000000034 method Methods 0.000 title abstract description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 34
- 238000003756 stirring Methods 0.000 claims abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 19
- 239000008213 purified water Substances 0.000 claims abstract description 12
- 230000008961 swelling Effects 0.000 claims abstract description 6
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000001768 carboxy methyl cellulose Substances 0.000 claims abstract 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims abstract 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims abstract 3
- 239000000243 solution Substances 0.000 claims description 13
- 238000007872 degassing Methods 0.000 claims description 5
- 239000011550 stock solution Substances 0.000 claims description 5
- 230000002421 anti-septic effect Effects 0.000 claims description 3
- 238000013019 agitation Methods 0.000 claims description 2
- 239000011734 sodium Substances 0.000 abstract description 17
- 239000003814 drug Substances 0.000 abstract description 11
- 235000011187 glycerol Nutrition 0.000 abstract description 11
- 210000004877 mucosa Anatomy 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 7
- 238000010521 absorption reaction Methods 0.000 abstract description 2
- 230000014759 maintenance of location Effects 0.000 abstract description 2
- 239000000853 adhesive Substances 0.000 abstract 1
- 230000001070 adhesive effect Effects 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 206010070834 Sensitisation Diseases 0.000 description 16
- 230000008313 sensitization Effects 0.000 description 16
- 238000012360 testing method Methods 0.000 description 11
- 206010015150 Erythema Diseases 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 8
- 206010030113 Oedema Diseases 0.000 description 8
- 231100000321 erythema Toxicity 0.000 description 8
- 229940079593 drug Drugs 0.000 description 7
- 230000007794 irritation Effects 0.000 description 6
- 241000700199 Cavia porcellus Species 0.000 description 5
- 206010052428 Wound Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000035617 depilation Effects 0.000 description 5
- 210000001215 vagina Anatomy 0.000 description 5
- 201000004624 Dermatitis Diseases 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 238000012856 packing Methods 0.000 description 4
- 230000037396 body weight Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- LOTKRQAVGJMPNV-UHFFFAOYSA-N 1-fluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C([N+]([O-])=O)=C1 LOTKRQAVGJMPNV-UHFFFAOYSA-N 0.000 description 2
- 206010006784 Burning sensation Diseases 0.000 description 2
- 206010046914 Vaginal infection Diseases 0.000 description 2
- 201000008100 Vaginitis Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 206010051814 Eschar Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 208000008350 Pruritus Vulvae Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000006374 Uterine Cervicitis Diseases 0.000 description 1
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 206010008323 cervicitis Diseases 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 231100000333 eschar Toxicity 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000000025 haemostatic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 239000006216 vaginal suppository Substances 0.000 description 1
- 229940120293 vaginal suppository Drugs 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
皮肤过敏反应(红斑) | 分值 | 皮肤过敏反应(水肿) | 分值 |
无红斑 | 0 | 无水肿 | 0 |
轻度红斑,勉强可见 | 1 | 轻度水肿,勉强可见 | 1 |
中度红斑,明显可见 | 2 | 中度水肿,明显可见(边缘高出周围皮肤) | 2 |
重度红斑 | 3 | 重度水肿,皮肤隆起1mm,轮廓清楚 | 3 |
紫红色红斑到轻度焦痂形成 | 4 | 严重水肿,皮肤隆起1mm以上或有水泡或破溃 | 4 |
致敏发生率(%) | 皮肤致敏性评价 |
0~10 | 无致敏性 |
11~30 | 轻度致敏性 |
31~60 | 中度致敏性 |
61~80 | 高度致敏性 |
81~100 | 极度致敏性 |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100905288A CN100496508C (zh) | 2006-06-28 | 2006-06-28 | 一种聚甲酚磺醛凝胶剂、其制备方法及药物用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100905288A CN100496508C (zh) | 2006-06-28 | 2006-06-28 | 一种聚甲酚磺醛凝胶剂、其制备方法及药物用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101095658A CN101095658A (zh) | 2008-01-02 |
CN100496508C true CN100496508C (zh) | 2009-06-10 |
Family
ID=39009881
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100905288A Active CN100496508C (zh) | 2006-06-28 | 2006-06-28 | 一种聚甲酚磺醛凝胶剂、其制备方法及药物用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100496508C (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103191163B (zh) * | 2013-04-29 | 2014-07-09 | 崔新明 | 一种皮肤创面修复药物组合物 |
CN104297462B (zh) * | 2014-11-07 | 2016-10-26 | 青岛泉佳美硅藻泥科技有限公司 | 一种硅藻提取物抗菌材料的安全性能评价方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1480151A (zh) * | 2002-09-04 | 2004-03-10 | 黄振华 | 聚甲酚磺醛洗剂 |
CN1593386A (zh) * | 2004-06-30 | 2005-03-16 | 上海复康医药科技发展有限公司 | 一种温度敏感的阴道用原位凝胶制剂 |
CN1771989A (zh) * | 2005-11-04 | 2006-05-17 | 山东恒瑞医药科技发展有限公司 | 一种治疗妇科炎症的复方制剂 |
-
2006
- 2006-06-28 CN CNB2006100905288A patent/CN100496508C/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1480151A (zh) * | 2002-09-04 | 2004-03-10 | 黄振华 | 聚甲酚磺醛洗剂 |
CN1593386A (zh) * | 2004-06-30 | 2005-03-16 | 上海复康医药科技发展有限公司 | 一种温度敏感的阴道用原位凝胶制剂 |
CN1771989A (zh) * | 2005-11-04 | 2006-05-17 | 山东恒瑞医药科技发展有限公司 | 一种治疗妇科炎症的复方制剂 |
Also Published As
Publication number | Publication date |
---|---|
CN101095658A (zh) | 2008-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108853312B (zh) | 聚桂醇外用凝胶及其制备方法 | |
CN101209267B (zh) | 红色诺卡氏菌细胞壁骨架在制备治疗皮肤损伤和疮疡的药物中的用途 | |
CN101361790A (zh) | 治疗皮炎湿疹、蚊虫叮咬所致瘙痒药物及用途 | |
CN103920072A (zh) | 一种壳聚糖抗菌凝胶及其制备方法 | |
CN108158995A (zh) | 一种含有壳聚糖的妇科用抗菌泡沫剂及其制备方法 | |
CN105169456B (zh) | 一种医用生物痔疮水凝胶功能性敷料及其制备方法 | |
CN103316262B (zh) | 一种妇科外用抗菌液及其制备方法 | |
CN101874809A (zh) | 一种使用甘油dmso混合溶剂的局部抗炎外用药物组合物 | |
CN100496508C (zh) | 一种聚甲酚磺醛凝胶剂、其制备方法及药物用途 | |
CN101292997A (zh) | 一种治疗烧烫伤或胃溃疡的药物组合物及其制备方法 | |
CN101829130A (zh) | 复方白藜芦醇抗炎止痒药物组合及用途 | |
CN102283899B (zh) | 一种中药外用制剂及其用途 | |
CN102370730A (zh) | 一种治疗骨关节炎的自热式中药贴膏剂 | |
CN102309517A (zh) | 药物组合物在制备治疗风湿的药物中的用途 | |
CN100348202C (zh) | 一种治疗皮肤病的口服复方制剂 | |
CN108938703A (zh) | 快速抗菌的妇科凝胶 | |
CN106822321B (zh) | 伤科黄水在制备治疗毛周角化症的药物中的应用 | |
CN107596370A (zh) | 一种治疗宫颈糜烂的药物复方制剂及用途 | |
CN100551368C (zh) | 环吡酮胺凝胶剂、其制备方法及药物用途 | |
JP5998399B1 (ja) | 痒み防止剤 | |
CN101837068B (zh) | 椒目仁油喷雾剂的制备工艺和应用 | |
CN111631991A (zh) | 一种私密护理洗液 | |
CN108403721A (zh) | 水石痔疮膏及其制备方法 | |
CN102349920A (zh) | 一种用于创面的磺胺类药物组合物 | |
CN102370777A (zh) | 治疗未破溃冻疮的药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: GUIYANG XINTIAN PHARMACEUTICAL INDUSTRY CO., LTD. Free format text: FORMER OWNER: SHANGHAI HUILUN TECHNOLOGY CO., LTD. Effective date: 20110302 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 200023 16A, HAIXING PLAZA, NO.1, RUIJIN SOUTH ROAD, SHANGHAI TO: 550018 NO.114, XINTIAN AVENUE, WUDANG DISTRICT, GUIYANG CITY |
|
TR01 | Transfer of patent right |
Effective date of registration: 20110302 Address after: 114 No. 550018 Guiyang District of Wudang City Xintian Avenue Patentee after: GUIYANG XIN TIAN PHARMACEUTICAL Co.,Ltd. Address before: 200023 Shanghai city Ruijin road Haixing Plaza No. 1 16A Patentee before: SHANGHAI HUILUN LIFE SCIENCE & TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190107 Address after: Room 650-10, Building No. 2, 351 Guoshoujing Road, Zhangjiang High-tech Park, Pudong New Area, Shanghai, 201203 Patentee after: SHANGHAI HUILUN LIFE SCIENCE & TECHNOLOGY Co.,Ltd. Address before: No. 114 Xintian Avenue, Wudang District, Guiyang City Patentee before: GUIYANG XIN TIAN PHARMACEUTICAL Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 201100 floor 10, building 5, No. 525, Yuanjiang Road, Minhang District, Shanghai Patentee after: Shanghai Hui Bio Technology Co.,Ltd. Address before: Room 650-10, building 2, 351 GuoShouJing Road, Zhangjiang High Tech Park, Pudong New Area, Shanghai 201203 Patentee before: SHANGHAI HUILUN LIFE SCIENCE & TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211224 Address after: 201100 floor 10, building 5, No. 525, Yuanjiang Road, Minhang District, Shanghai Patentee after: Shanghai Hui Bio Technology Co.,Ltd. Patentee after: SHANGHAI HUILUN JIANGSU PHARMACEUTICAL Co.,Ltd. Address before: 201100 floor 10, building 5, No. 525, Yuanjiang Road, Minhang District, Shanghai Patentee before: Shanghai Hui Bio Technology Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 200241 floor 10, building 5, No. 525, Yuanjiang Road, Minhang District, Shanghai Patentee after: Shanghai Huilun Pharmaceutical Co.,Ltd. Patentee after: SHANGHAI HUILUN JIANGSU PHARMACEUTICAL Co.,Ltd. Address before: 201100 floor 10, building 5, No. 525, Yuanjiang Road, Minhang District, Shanghai Patentee before: Shanghai Hui Bio Technology Co.,Ltd. Patentee before: SHANGHAI HUILUN JIANGSU PHARMACEUTICAL Co.,Ltd. |